Dashboard
Manage Tickers

BAXBAXTER INTERNATIONAL INC

NYSE baxter.com


$ 38.95 $ 0.13 (0.33 %)    

Friday, 06-Sep-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.50 $ -14.72 (-3.19 %)
DIA $ 404.28 $ -4.18 (-1.02 %)
SPY $ 539.90 $ -9.71 (-1.77 %)
TLT $ 99.49 $ -0.06 (-0.06 %)
GLD $ 230.65 $ -1.70 (-0.73 %)
$ 38.82
$ 38.95
$ 38.95 x 100
$ 38.98 x 100
$ 38.41 - $ 39.48
$ 30.05 - $ 43.29
6,375,743
na
19.81B
$ 0.63
$ 8.00
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-08-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-09-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-11-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 03-17-2020 09-30-2019 10-Q
20 03-17-2020 12-31-2019 10-K
21 07-30-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-21-2019 12-31-2018 10-K
24 11-05-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-06-2015 03-31-2015 10-Q
39 02-26-2015 12-31-2014 10-K
40 10-29-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

medtronic-recalls-some-video-laryngoscopes-due-to-increased-risk-for-battery-overheat-explosion
Medtronic Recalls Some Video Laryngoscopes...
09/05/2024 17:45:41

Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.

fda-says-baxter-healthcare-recalls-certain-volara-system-single-patient-use-circuits-and-blue-ventilator-adapter-assemblies-identified-baxters-recall-of-certain-single-patient-use-circuits--blue-ventilator-adapter-assemblies-as-most-serious-type-baxter-healthcare-recall-due-to-disconnection-risk-that-may-prevent-proper-ventilation
FDA Says Baxter Healthcare Recalls Certain...
09/04/2024 15:33:35

- Reuters

baxter-and-brian-stevens-mutually-agree-that-he-will-resign-from-his-role-as-senior-vice-president-chief-accounting-officer-and-controller-and-principal-accounting-officer---filing
Baxter And Brian Stevens Mutually Agree Th...
09/03/2024 20:51:05

On September 3, 2024, the Board of Directors of the Company approved the appointment of Joel Grade, the Company’s Executive Vic...

rivian-chipotle-mexican-and-sirius-xm-are-among-top-10-large-cap-losers-last-week-aug-11-aug-17-are-the-others-in-your-portfolio
Rivian, Chipotle Mexican And Sirius XM Are...
08/18/2024 17:06:46

Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all see...

baxter-seals-38b-deal-with-carlyle-for-its-kidney-care-segment
Baxter Seals $3.8B Deal With Carlyle For I...
08/13/2024 15:07:11

Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, ...

baxter-intends-to-use-after-tax-proceeds-from-kidney-care-transaction-to-reduce-its-debt-consistent-with-its-stated-capital-allocation-priorities
Baxter Intends To Use After-Tax Proceeds F...
08/13/2024 11:06:50

The transaction is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satis...

following-completion-of-pending-sale-of-kidney-care-baxter-targets-operational-sales-growth-of-4-to-5-annually
Following Completion Of Pending Sale Of Ki...
08/13/2024 11:05:33

For 2025, the company anticipates an adjusted operating margin of approximately 16.5% on a continuing operations basis, which r...

baxter-shares-are-trading-higher-after-the-company-announced-a-definitive-agreement-to-divest-its-vantive-kidney-care-segment-to-carlyle-for-38-billion
Baxter shares are trading higher after the...
08/13/2024 11:05:29

Core News & Articles
Carlyle To Acquire Baxter's Kidney Care Se...
08/13/2024 11:00:53

goldman-sachs-maintains-neutral-on-baxter-intl-raises-price-target-to-40
Goldman Sachs Maintains Neutral on Baxter ...
08/08/2024 15:19:22

Goldman Sachs analyst David Roman maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $36 to $40.

jp-morgan-maintains-neutral-on-baxter-intl-lowers-price-target-to-42
JP Morgan Maintains Neutral on Baxter Intl...
08/07/2024 18:02:03

JP Morgan analyst Robbie Marcus maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $44 to $42.

the-latest-analyst-ratings-for-baxter-intl
The Latest Analyst Ratings For Baxter Intl
08/07/2024 17:02:51

wells-fargo-maintains-equal-weight-on-baxter-intl-lowers-price-target-to-40
Wells Fargo Maintains Equal-Weight on Baxt...
08/07/2024 14:14:08

Wells Fargo analyst Larry Biegelsen maintains Baxter Intl (NYSE:BAX) with a Equal-Weight and lowers the price target from $4...

fda-says-on-aug-5-baxter-issues-voluntary-nationwide-recall-of-one-lot-of-heparin-sodium-09-sodium-chloride-injection-baxter-issues-recall-of-one-lot-of-heparin-sodium-09-sodium-chloride-injection-due-to-potential-for-elevated-endotoxin-levels
FDA Says On Aug 5, Baxter Issues Voluntary...
08/06/2024 15:10:40

- Reuters

baxter-lifts-annual-outlook-after-strong-q2-beat-medical-devices-sales
Baxter Lifts Annual Outlook After Strong Q...
08/06/2024 13:59:42

Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant...

for-q3-baxter-expects-sales-growth-of-3-4-on-a-reported-basis-and-4-5-on-a-constant-currency-basis-with-adjusted-eps-of-077-079-versus-consensus-of-066
For Q3 Baxter Expects Sales Growth Of 3%-4...
08/06/2024 11:22:28

baxter-now-expects-2024-sales-growth-of-approximately-3-on-reported-and-constant-currency-basis-compared-to-prior-guidance-of-2-and-2-3-respectively
Baxter Now Expects 2024 Sales Growth Of Ap...
08/06/2024 11:20:58

baxter-forecasts-2024-adjusted-eps-of-293-301-versus-prior-guidance-of-288-298-and-consensus-of-291
Baxter Forecasts 2024 Adjusted EPS Of $2.9...
08/06/2024 11:18:59

baxter-intl-q2-2024-adj-eps-068-beats-066-estimate-sales-3812b-beat-3755b-estimate
Baxter Intl Q2 2024 Adj. EPS $0.68 Beats $...
08/06/2024 11:16:23

carlyles-4b-purchase-of-baxters-kidney-division-backed-by-ares-and-hps-financing
Carlyle's $4B Purchase Of Baxter's Kidney ...
07/24/2024 19:16:17

Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION